| Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy D Finzi, M Hermankova, T Pierson, LM Carruth, C Buck, RE Chaisson, ... Science 278 (5341), 1295-1300, 1997 | 3429 | 1997 |
| Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy D Finzi, J Blankson, JD Siliciano, JB Margolick, K Chadwick, T Pierson, ... Nature medicine 5 (5), 512-517, 1999 | 2503 | 1999 |
| Targeted tuberculin testing and treatment of latent tuberculosis infection Centers for Disease Control and Prevention Mmwr 49 (6), 1-54, 2000 | 1423* | 2000 |
| Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection MS Sulkowski, DL Thomas, RE Chaisson, RD Moore Jama 283 (1), 74-80, 2000 | 1262 | 2000 |
| American thoracic society/centers for disease control and prevention/infectious diseases society of America: treatment of tuberculosis HM Blumberg, WJ Burman, RE Chaisson, CL Daley American journal of respiratory and critical care medicine 167 (4), 603, 2003 | 1249* | 2003 |
| Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible … P Nahid, SE Dorman, N Alipanah, PM Barry, JL Brozek, A Cattamanchi, ... Clinical Infectious Diseases 63 (7), e147-e195, 2016 | 1138 | 2016 |
| Tuberculosis and diabetes mellitus: convergence of two epidemics KE Dooley, RE Chaisson The Lancet infectious diseases 9 (12), 737-746, 2009 | 1133 | 2009 |
| Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions GM Lucas, RE Chaisson, RD Moore Annals of internal medicine 131 (2), 81-87, 1999 | 1039 | 1999 |
| Three months of rifapentine and isoniazid for latent tuberculosis infection TR Sterling, ME Villarino, AS Borisov, N Shang, F Gordin, ... New England Journal of Medicine 365 (23), 2155-2166, 2011 | 970 | 2011 |
| USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus Centers for Disease Control and Prevention MMWR Morb Mortal Wkly Rep 46 (RR-12), 1-46, 1997 | 865* | 1997 |
| Cocaine use and HIV infection in intravenous drug users in San Francisco RE Chaisson, P Bacchetti, D Osmond, B Brodie, MA Sande, AR Moss Jama 261 (4), 561-565, 1989 | 805 | 1989 |
| Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort AR Moss, P Bacchetti, D Osmond, W Krampf, RE Chaisson, D Stites, ... Br Med J (Clin Res Ed) 296 (6624), 745-750, 1988 | 755 | 1988 |
| Latent Mycobacterium tuberculosis Infection H Getahun, A Matteelli, RE Chaisson, M Raviglione New England Journal of Medicine 372 (22), 2127-2135, 2015 | 754 | 2015 |
| Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine JE Gallant, RD Moore, DD Richman, J Keruly, RE Chaisson, ... Journal of Infectious Diseases 166 (6), 1223-1227, 1992 | 743 | 1992 |
| Hepatotoxicity associated with nevirapine or efavirenz‐containing antiretroviral therapy: role of hepatitis C and B infections MS Sulkowski, DL Thomas, SH Mehta, RE Chaisson, RD Moore Hepatology 35 (1), 182-189, 2002 | 718 | 2002 |
| Tuberculosis in patients with the acquired immunodeficiency syndrome RE Chaisson, GF Schecter, CP Theuer, GW Rutherford, DF Echenberg, ... Am Rev Respir Dis 136 (570), 37, 1987 | 669 | 1987 |
| Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection PM Small, GF Schecter, PC Goodman, MA Sande, RE Chaisson, ... New England Journal of Medicine 324 (5), 289-294, 1991 | 641 | 1991 |
| Hepatitis C and progression of HIV disease MS Sulkowski, RD Moore, SH Mehta, RE Chaisson, DL Thomas Jama 288 (2), 199-206, 2002 | 625 | 2002 |
| Natural history of HIV infection in the_era of combination antiretroviral therapy RD Moore, RE Chaisson Aids 13 (14), 1933-1942, 1999 | 625 | 1999 |
| Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries H Getahun, A Matteelli, I Abubakar, MA Aziz, A Baddeley, D Barreira, ... European Respiratory Journal 46 (6), 1563-1576, 2015 | 590 | 2015 |
Jonathan GolubProfessor, Johns Hopkins UniversityVerified email at jhmi.edu
